Description
SK-GT-4 was established from a primary tumour in 1989 from a 89 year-old Caucasian male who presented with dysphagia secondary to a well-differentiated adenocarcinoma arising in the Barrett epithelium of the distal oesophagus. The tumour invaded into but not through the muscle layer (T2) and involved 3 of 14 lymph nodes (N1). SK-GT-4 was found to be tumorigenic in athymic nu/nu mice.
Adherent Suspension
Adherent
Suggested Medium
RPMI-1640 + 2mM Glutamine + 10% Foetal Bovine Serum (FBS)
Quality Control
SK-GT-4 Cell Line was tested and found to be free of mycoplasma, bacterial, viruses, and other toxins. All cells were above 95% viability before freezing.
Morphology
Epithelial growing in islands
Shippment
SK-GT-4 Cell Line will be shipped using dry ice.
Storage
Store the cell lines in liquid nitrogen vapor (less than -130°C)
Warranty
SK-GT-4 Cell Line is for research use only
